Cannabis, a potential treatment option in pediatric IBD? Still a long way to go

References

• Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011 Jan;17(1):423–439. PubMed PMID: 20564651.
   PubMed Web of Science ®Google Scholar
• Lal S, Prasad N, Ryan M, et al. Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891–896. PubMed PMID: 21795981; eng.
   PubMed Web of Science ®Google Scholar
• Phatak UP, Rojas-Velasquez D, Porto A, et al. Prevalence and patterns of marijuana use in young adults with inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):261–264. PubMed PMID: 27846066; eng.
   PubMed Web of Science ®Google Scholar
• Ravikoff Allegretti J, Courtwright A, Lucci M, et al. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Dec;19(13):2809–2814. PubMed PMID: 24185313; PubMed Central PMCID: PMCPMC4126607. eng.
   PubMed Web of Science ®Google Scholar
• Storr M, Devlin S, Kaplan GG, et al. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease. Inflamm Bowel Dis. 2014 Mar;20(3):472–480. PubMed PMID: 24407485; eng.
   PubMed Web of Science ®Google Scholar
• Weiss A, Friedenberg F. Patterns of cannabis use in patients with inflammatory Bowel Disease: A population based analysis. Drug Alcohol Depend. 2015 Nov 1;156:84–89. PubMed PMID: 26422462; eng.
   PubMed Web of Science ®Google Scholar
• Kelsen J, Baldassano RN. Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis. 2008 Oct;14(Suppl 2):S9–S11. PubMed PMID: 18816756; eng.
   PubMedGoogle Scholar
• Hoffenberg EJ, McWilliams SK, Mikulich-Gilbertson SK, et al. Marijuana use by adolescents and young adults with inflammatory Bowel Disease. J Pediatr. 2018 Aug;199:99–105. PubMed PMID: 29673723; eng.
   PubMed Web of Science ®Google Scholar
• Greineisen WE, Turner H. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists. Int Immunopharmacol. 2010 May;10(5):547–555. PubMed PMID: 20219697; PubMed Central PMCID: PMCPMC3804300. eng.
   PubMed Web of Science ®Google Scholar
• Wright K, Rooney N, Feeney M, et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology. 2005 Aug;129(2):437–453. PubMed PMID: 16083701; eng.
   PubMed Web of Science ®Google Scholar
• Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol. 2008 Jan;153(2):263–270. PubMed PMID: 17906675; PubMed Central PMCID: PMCPMC2219529. eng.
   PubMed Web of Science ®Google Scholar
• Schicho R, Storr M. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol. 2011 Jul;25(7):377–383. PubMed PMID: 21876860; PubMed Central PMCID: PMCPMC3174079. eng.
   PubMedGoogle Scholar
• Goyal H, Singla U, Gupta U, et al. Role of cannabis in digestive disorders. Eur J Gastroenterol Hepatol. 2017 Feb;29(2):135–143. PubMed PMID: 27792038; eng.
   PubMed Web of Science ®Google Scholar
• Hasenoehrl C, Taschler U, Storr M, et al. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterol Motil Off J Eur Gastrointestinal Motil Soc. 2016 Dec;28(12):1765–1780. PubMed PMID: 27561826; PubMed Central PMCID: PMCPMC5130148. eng.
   PubMed Web of Science ®Google Scholar
• Gyires K, Zadori ZS. Role of cannabinoids in gastrointestinal mucosal defense and inflammation. Curr Neuropharmacol. 2016;14(8):935–951. PubMed PMID: 26935536; PubMed Central PMCID: PMCPMC5333598. eng.
   PubMed Web of Science ®Google Scholar
• Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med (Berlin, Germany). 2005 Dec;83(12):944–954. PubMed PMID: 16133420; eng.
   PubMed Web of Science ®Google Scholar
• Leinwand KL, Gerich ME, Hoffenberg EJ, et al. Manipulation of the endocannabinoid system in colitis: a comprehensive review. Inflamm Bowel Dis. 2017 Feb;23(2):192–199. PubMed PMID: 28079617; eng.
   PubMed Web of Science ®Google Scholar
• Hasenoehrl C, Storr M, Schicho R. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):329–337. PubMed PMID: 28276820; PubMed Central PMCID: PMCPMC5388177. eng.
   PubMed Web of Science ®Google Scholar
• Nallathambi R, Mazuz M, Ion A, et al. Anti-inflammatory activity in colon models is derived from Delta9-Tetrahydrocannabinolic Acid that interacts with additional compounds in cannabis extracts. Cannabis Cannabinoid Res. 2017;2(1):167–182. PubMed PMID: 29082314; PubMed Central PMCID: PMCPMC5627671. eng.
   PubMedGoogle Scholar
• Ahmed W, Katz S. Therapeutic use of cannabis in inflammatory Bowel Disease. Gastroenterol Hepatol. 2016 Nov;12(11):668–679. PubMed PMID: 28035196; PubMed Central PMCID: PMCPMC5193087. eng.
   Google Scholar
• Esposito G, Filippis DD, Cirillo C, et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother Res. 2013 May;27(5):633–636. PubMed PMID: 22815234; eng.
   PubMed Web of Science ®Google Scholar
• Lahat A, Lang A, Ben-Horin S. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study. Digestion. 2012;85(1):1–8. PubMed PMID: 22095142; eng.
   PubMed Web of Science ®Google Scholar
• Naftali T, Bar-Lev Schleider L, Dotan I, et al. Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study. Clinical gastroenterology and hepatology. Off Clin Pract J Am Gastroenterol Assoc. 2013 Oct;11(10):1276–1280. e1. PubMed PMID: 23648372; eng.
   Web of Science ®Google Scholar
• Naftali T, Lev LB, Yablecovitch D, et al. Treatment of Crohn’s disease with cannabis: an observational study. Isr Med Assoc J. 2011 Aug;13(8):455–458. PubMed PMID: 21910367; eng.
   PubMed Web of Science ®Google Scholar
• Naftali T, Mechulam R, Marii A, et al. Low-dose cannabidiol is safe but not effective in the treatment for Crohn’s Disease, a randomized controlled trial. Dig Dis Sci. 2017 Jun;62(6):1615–1620. PubMed PMID: 28349233; eng.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997;74(2):129–180. PubMed PMID: 9336020; eng.
   PubMed Web of Science ®Google Scholar
• Biegon A, Kerman IA. Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. NeuroImage. 2001 Dec;14(6):1463–1468. PubMed PMID: 11707102; eng.
   PubMed Web of Science ®Google Scholar
• Fride E. The endocannabinoid-CB receptor system: importance for development and in pediatric disease. Neuro Endocrinol Lett. 2004 Feb-Apr;25(1–2):24–30. PubMed PMID: 15159678; eng.
   PubMed Web of Science ®Google Scholar
• Fride E, Gobshtis N, Dahan H, et al. The endocannabinoid system during development: emphasis on perinatal events and delayed effects. Vitam Horm. 2009;81:139–158. PubMed PMID: 19647111; eng.
   PubMed Web of Science ®Google Scholar
• Camchong J, Lim KO, Adverse KS. Effects of cannabis on adolescent brain development: a longitudinal study. Cereb Cortex. 2017 Mar 1;27(3):1922–1930. PubMed PMID: 26912785.
   PubMed Web of Science ®Google Scholar
• Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657–64. . PubMed PMID: 22927402; PubMed Central PMCID: PMCPMC3479587. eng.
   PubMed Web of Science ®Google Scholar
• Zucker RA, Gonzalez R, Feldstein Ewing SW, et al. Assessment of culture and environment in the adolescent brain and cognitive development study: rationale, description of measures, and early data. Dev Cogn Neurosci. 2018 Aug;32:107–120. PubMed PMID: 29627333; eng.
   PubMed Web of Science ®Google Scholar
• Mandelbaum DE, de la Monte SM. Adverse structural and functional effects of marijuana on the brain: evidence reviewed. Pediatr Neurol. 2017 Jan;66:12–20. PubMed PMID: 27789118; eng.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM, Evins AE, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA psychiatry. 2016 Mar;73(3):292–297. PubMed PMID: 26842658; eng.
   PubMed Web of Science ®Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (London, England). 2007 Jul 28;370(9584):319–328. PubMed PMID: 17662880; eng
   PubMed Web of Science ®Google Scholar
• Lubman DI, Cheetham A, Yucel M. Cannabis and adolescent brain development. Pharmacol Ther. 2015 Apr;148:1–16. PubMed PMID: 25460036; eng.
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Hanus L. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects. Chem Phys Lipids. 2002 Dec 31;121(1–2):35–43. PubMed PMID: 12505688; eng.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the dravet syndrome. N Engl J Med. 2017 May 25;376(21):2011–2020. PubMed PMID: 28538134; eng.
   PubMed Web of Science ®Google Scholar
• Kaplan EH, Offermann EA, Sievers JW, et al. Cannabidiol treatment for refractory seizures in sturge-weber syndrome. Pediatr Neurol. 2017 Jun;71:18–23. e2. PubMed PMID: 28454984; eng.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Patel AD, Cross JH, et al. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome. N Engl J Med. 2018 May 17;378(20):1888–1897. PubMed PMID: 29768152; eng.
   PubMed Web of Science ®Google Scholar
• Giacoppo S, Bramanti P, Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation. Mult Scler Relat Disord. 2017 Oct;17:22–31. PubMed PMID: 29055461; eng.
   PubMed Web of Science ®Google Scholar
• Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2017 Sep;20(6):E755–e796. PubMed PMID: 28934780; eng.
   PubMed Web of Science ®Google Scholar
• Dalzell AM, Bartlett H, Lilleyman JS. Nabilone: an alternative antiemetic for cancer chemotherapy. Arch Dis Child. 1986 May;61(5):502–505. PubMed PMID: 3013104; PubMed Central PMCID: PMCPMC1777777. eng.
   PubMed Web of Science ®Google Scholar
• Salaga M, Sobczak M, Fichna J. Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract. Eur J Pharm Sci. 2014 Feb 14;52:173–179. PubMed PMID: 24275607; eng.
   PubMed Web of Science ®Google Scholar
• Salaga M, Mokrowiecka A, Zakrzewski PK, et al. Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). J Crohn’s Colitis. 2014 Sep;8(9):998–1009. PubMed PMID: 24530133; PubMed Central PMCID: PMCPMC4136976. eng.
   Google Scholar
• Alhouayek M, Lambert DM, Delzenne NM, et al. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J. 2011 Aug;25(8):2711–2721. PubMed PMID: 21551239; eng.
   PubMed Web of Science ®Google Scholar
• Richards JR, Smith NE, Moulin AK. Unintentional cannabis ingestion in children: A systematic review. J Pediatr. 2017 Nov;190:142–152. PubMed PMID: 28888560; eng.
   PubMed Web of Science ®Google Scholar
• De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS one. 2011;6(12):e28159. PubMed PMID: 22163000; PubMed Central PMCID: PMCPMC3232190. eng.
   PubMed Web of Science ®Google Scholar